Trial Profile
A Retrospective, Cohort Study to Evaluate the Long Term Efficacy and Safety of Adalimumab in Patients with Refractory Ulcerative Colitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- 20 Aug 2015 New trial record